期刊文献+

小分子化合物扩增造血干细胞的研究进展 被引量:3

Small-molecular compounds to expand hematopoietic stem cells
原文传递
导出
摘要 应用骨髓移植治疗白血病等恶性血液疾病已有50多年的历史。但骨髓中造血干细胞(Hsc)数量较低,移植后难以在患者体内有效进行造血重建,这也成为HSC临床应用的一个瓶颈。之前研究者曾采用加入多种细胞因子的液体培养基、与基质细胞共同培养或在生物反应器中培养等方法体外扩增造血干,祖细胞(HSPC),但上述方法仍不能获得充足的具有植活能力的HSPC用于临床治疗。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2014年第1期82-85,共4页 Chinese Journal of Hematology
基金 国家自然科学基金(81170465)
  • 相关文献

参考文献39

  • 1Nishino T,Osawa M,Iwama A. New approaches to expand hematopoietic stem and progenitor cells[J].Expert Opinion on Biological Therapy,2012,(06):743-756.
  • 2Walasek MA,van Os R,de Haan G. Hematopoietic stem cell expansion:challenges and opportunities[J].Annals of the New York Academy of Sciences,2012.138-150.
  • 3Zhang Y,Li W,Laurent T. Small molecules,big roles-the chemical manipulation of stem cell fate and somatic cell reprogramming[J].Journal of Cell Science,2012,(Pt 23):5609-5620.
  • 4Boitano AE,Wang J,Romeo R. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells[J].Science,2010,(5997):1345-1348.
  • 5Singh KP,Casado FL,Opanashuk LA. The aryl hydrocarbon receptor has a normal function in the regulation of hematopoietic and other stem/progenitor cell populations[J].Biochemical Pharmacology,2009,(04):577-587.
  • 6Ying QL,Wray J,Nichols J. The ground state of embryonic stem cell self-renewal[J].NATURE,2008,(7194):519-523.
  • 7Li W,Zhou H,Abujarour R. Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2[J].STEM CELLS,2009,(12):2992-3000.
  • 8Perry JM,He XC,Sugimura R. Cooperation between both Wnt/{beta}-catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion[J].Genes & Development,2011,(18):1928-1942.
  • 9Huang J,Nguyen-McCarty M,Hexner EO. Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways[J].Nature Medicine,2012,(12):1778-1785.
  • 10Chen C,Liu Y,Liu R. TSC-mTOR maintains quiescence and function of hematopoietic stem ceils by repressing mitochondrial biogenesis and reactive oxygen species[J].Journal of Experimental Medicine,2008,(10):2397-2408.

同被引文献41

  • 1刘颖中,钟雁,王亚娟.湿疹-血小板减少紫癜综合征1例报告及文献复习[J].中国当代儿科杂志,2006,8(6):499-501. 被引量:5
  • 2Braun C J, Boztug K, Paruzynski A, et al. Gene therapy for Wiskott-Aldrich syndrome-long-term efficacy and genotoxicity [J]. Sci Transl Med, 2014, 6(227):227 ra33.
  • 3Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome [J]. J Allergy Clin Immunol, 2006, 117(4): 725-738; quiz 739.
  • 4Buchbinder D, Nugent D J, Fillipovich AH. Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treat- ments[Jl. Appl Clin Genet, 2014, 7: 55-66.
  • 5Jin Y, Mazza C, Christie JR, et al. Mutations of the Wiskott- Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation [ J ]. Blood, 2004, 104 ( 13 ) :4010-4019.
  • 6Ozsahin H, Cavazzana-Calvo M, Notarangelo LD, et al. Long- term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the Europe- an Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation [J]. Blood, 2008, 111 ( 1 ): 439-445.
  • 7Proust A, Guillet B, Pellier I, et al. Recurrent V75M mutationwithin the Wiskott-Aldrich syndrome protein: description of a homozygous female patient [J]. Eur J Haematol, 2005, 75 ( 1 ): 54-59.
  • 8Massaad MJ, Ramesh N, Geha RS. Wiskott-Aldrich syndrome: a comprehensive review [J]. Ann N Y Acad Sci, 2013, 1285:26- 43.
  • 9Ariga T. Wiskott-Aldrich syndrome; an x-linked primary immunodeficiency disease with unique and characteristic features[J]. Allergol Int, 2012, 61(2):183-189.
  • 10Gublcsy V, Mar6di L. Wiskott-Aldrich syndrome [J]. Orv Hetil, 2008, 149(29): 1367-1371.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部